Skip to main content
. Author manuscript; available in PMC: 2008 Jan 5.
Published in final edited form as: Neuroscience. 2006 Nov 2;144(1):223–231. doi: 10.1016/j.neuroscience.2006.08.073

Figure 2.

Figure 2

C-tau immunolabeling in the striatum and dentate gyrus regions of the hippocampus. Immunocytochemistry was performed with an antibody specific to cleaved MAP-tau (C-tau7) and striatal (panels A, C, E) and hippocampal (panels B, D, F) tissue of rats killed 3 days after treatment with VEH (panels A and B), METH (panels C and D) or MDMA (panels E and F). Drugs were administered as described in the legend of Table 1. Magnification, 20x.